Biocept Inc. (BIOCQ) — Working Capital to Net Assets Ratio
Biocept Inc. (BIOCQ) has a Working Capital to Net Assets ratio of 1364.8% as of June 2023. Working capital of $3.96 Million (current assets of $8.86 Million minus current liabilities of $4.90 Million) is measured against net assets of $290.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. See BIOCQ net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Biocept Inc. Working Capital to Net Assets (2019–2022)
This chart shows how Biocept Inc.'s Working Capital to Net Assets ratio has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the ratio stands at 1364.8%, reflecting working capital of $3.96 Million against net assets of $290.00K USD. Check BIOCQ goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Biocept Inc. (2019–2022)
The table below presents the year-by-year Working Capital to Net Assets ratio for Biocept Inc. from 2019 to 2022, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see BIOCQ market cap overview.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 122.3% | $10.84 Million | $8.86 Million | $16.34 Million | $5.51 Million | ▲ +31.8 pp |
| 2021 | 90.5% | $33.92 Million | $37.48 Million | $45.69 Million | $11.77 Million | ▲ +5.7 pp |
| 2020 | 84.8% | $20.10 Million | $23.69 Million | $32.59 Million | $12.49 Million | ▲ +10.4 pp |
| 2019 | 74.4% | $8.33 Million | $11.20 Million | $13.89 Million | $5.56 Million | — |